Read More Analyst Ratings Downgrades News Price Target Cantor Fitzgerald Downgrades Metromile to Neutral, Announces $7 Price Target By Benzinga Newsdesk Today, 5:28 AM Cantor Fitzgerald analyst Josh Siegler downgrades Metromile (NASDAQ:MILE) from Overweight to Neutral and announces $7 price target. MILE
Read More FDA News FDA Says Expects More Than 4.8M Cans Of Kendamil First Infant Formula With Iron From Global Kosher By Benzinga Newsdesk Today, 5:28 AM - Reuters ABT
Read More News ‘PSA: Snapchat for iOS is currently down, company investigating’ -9to5 Mac Report By Benzinga Newsdesk Today, 5:28 AM https://9to5mac.com/2021/10/13/snapchat-is-down-investigating/ SNAP
Read More Analyst Ratings News Price Target Goldman Sachs Maintains Buy on Target, Lowers Price Target to $175 By Benzinga Newsdesk Today, 5:28 AM Goldman Sachs analyst Kate McShane maintains Target (NYSE:TGT) with a Buy and lowers the price target from $205 to $175. TGT